Luigina Guasti Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

8/2019

Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigina Guasti Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2021 - 03/2002
5	Neoplasms (Cancer) 03/2021 - 01/2017
5	Dyslipidemias (Dyslipidemia) 09/2018 - 01/2011
5	Venous Thromboembolism 01/2018 - 05/2010
4	Inflammation (Inflammations) 12/2019 - 05/2006
4	Atrial Fibrillation 01/2018 - 08/2011
4	Atherosclerosis 01/2016 - 05/2007
3	Stroke (Strokes) 08/2019 - 07/2013
3	Acute Coronary Syndrome 09/2018 - 10/2011
3	Pulmonary Embolism 08/2017 - 07/2013
3	Essential Hypertension 02/2017 - 11/2002
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014 - 02/2006
3	Hypothyroidism 01/2014 - 02/2006
3	Heart Diseases (Heart Disease) 01/2014 - 01/2006
3	Hypertrophy 01/2012 - 11/2006
2	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2011
2	Ischemic Stroke 08/2019 - 01/2018
2	ST Elevation Myocardial Infarction 09/2018 - 01/2018
2	Chronic Hepatitis C 01/2018 - 12/2014
2	Hemorrhage 01/2018 - 04/2015
2	Thrombosis (Thrombus) 04/2015 - 07/2013
2	Peripheral Arterial Disease 01/2013 - 12/2009
2	Type 2 Diabetes Mellitus (MODY) 12/2012 - 04/2005
2	Thyroid Neoplasms (Thyroid Cancer) 07/2007 - 02/2006
2	Pain (Aches) 07/2007 - 03/2002
2	Insulin Resistance 04/2007 - 04/2005
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2021
1	Breast Neoplasms (Breast Cancer) 03/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Cardiotoxicity 03/2021
1	Heart Failure 01/2021
1	Vascular Diseases (Vascular Disease) 12/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2019
1	Diabetes Mellitus 08/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2018
1	Vitamin D Deficiency 10/2018
1	Colonic Neoplasms (Colon Cancer) 10/2018
1	Carcinoma (Carcinomatosis) 10/2018
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Non-ST Elevated Myocardial Infarction 09/2018
1	Coronary Disease (Coronary Heart Disease) 09/2018
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2017
1	Necrosis 01/2017
1	Embolism (Embolus) 10/2015

Drug/Important Bio-Agent (IBA)

8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 05/2007
7	Antihypertensive Agents (Antihypertensives)IBA 10/2007 - 03/2002
6	LipidsIBA 09/2018 - 04/2005
5	oxidized low density lipoproteinIBA 01/2022 - 04/2005
4	AnticoagulantsIBA 01/2018 - 12/2014
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017 - 03/2002
3	LDL CholesterolIBA 09/2018 - 11/2011
2	PCSK9 InhibitorsIBA 01/2022 - 10/2017
2	Vitamin D FDA LinkGeneric 12/2018 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 11/2011
2	CanrenoneIBA 01/2017 - 11/2002
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2012
2	Pharmaceutical PreparationsIBA 04/2015 - 03/2002
2	Apolipoproteins B (ApoB)IBA 09/2014 - 04/2005
2	Interleukin-8 (Interleukin 8)IBA 03/2014 - 12/2009
2	Thyroid HormonesIBA 01/2014 - 07/2007
2	Fibric Acids (Fibrates)IBA 12/2012 - 05/2010
2	Type 1 Angiotensin ReceptorIBA 12/2009 - 05/2006
2	Enalapril FDA LinkGeneric 04/2005 - 03/2002
1	AnthracyclinesIBA 03/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 12/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2019
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2018
1	Cetuximab (Erbitux)FDA Link 10/2018
1	VitaminsIBA 10/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 09/2018
1	omega-Chloroacetophenone (Mace)IBA 09/2018
1	Clopidogrel (Plavix)FDA Link 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 06/2017
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 02/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	apixabanIBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2022 - 04/2005
3	Percutaneous Coronary Intervention 01/2018 - 10/2011
2	Drug Therapy (Chemotherapy) 03/2021 - 10/2018
2	Secondary Prevention 08/2019 - 01/2018
2	Length of Stay 01/2018 - 08/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2015 - 10/2011
1	Ambulatory Care (Outpatient Care) 12/2019
1	Stents 04/2015